Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.31 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.31 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20008916 | 1.00 | LMNA (0.37) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL20008918 | 1.00 | LMNA (0.37) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL17195512 | 0.98 | LMNA (0.34) | LMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL17195511 | 0.92 | — | — | |
| SCHEMBL18785891 | 0.88 | LMNA (0.51) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL18785892 | 0.88 | LMNA (0.51) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL18785597 | 0.88 | LMNA (0.51) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL18785895 | 0.88 | LMNA (0.51) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL18785901 | 0.88 | LMNA (0.51) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL18785607 | 0.88 | LMNA (0.51) | LMNAMAPTMAPK1ALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180085019-A1 | ADHESIVE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING A BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |